14.12.2012 Views

Pharmacy Continence Care - Bladder and Bowel Website

Pharmacy Continence Care - Bladder and Bowel Website

Pharmacy Continence Care - Bladder and Bowel Website

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.6 Consumer participation<br />

Consumer participation in the project was a major aim with the objective of assessing the<br />

extent to which pharmacy provided information <strong>and</strong> assistance resulted in consumer benefit,<br />

including positive health behaviour or improved health outcome.<br />

Despite a carefully designed <strong>and</strong> well resourced consumer recruitment strategy, however,<br />

the participating pharmacies recruited less than one tenth of the target number of<br />

consumers for evaluation of the health <strong>and</strong> individual benefits of the Program. Feedback<br />

from a number of the participating pharmacies has suggested that pharmacy staff consider<br />

consumers are hesitant to participate because of their reluctance to publicly self-identify as<br />

having continence issues. Follow-up by the project team indicated that pharmacies do not<br />

have a practice of seeking customer feedback <strong>and</strong> this may also have been a contributory<br />

factor.<br />

To evaluate consumer benefits, pharmacies were asked to encourage <strong>and</strong> support customers<br />

to whom continence information, advice or referral was offered (people with or at risk of<br />

incontinence, <strong>and</strong> carers), to complete a baseline survey questionnaire in the pharmacy at<br />

the time of the intervention. In recognition of the time impost for customers likely to have<br />

limited time or interest in staying to complete a questionnaire after completing their visit to<br />

the pharmacy, incentives to participate were developed <strong>and</strong> identified in consumer<br />

information <strong>and</strong> on the consumer baseline survey questionnaire. Each consumer who<br />

consented to be part of the trial was issued a printed questionnaire, together with a printed<br />

reply-paid envelope addressed to the survey firm, Ipsos Australia, to protect respondent<br />

confidentiality.<br />

The consumer recruitment target established by the project team, after literature review <strong>and</strong><br />

consultation with members of the NOVA Expert Panel, was 500 consumers, an average of 10<br />

consumers to be recruited by each pharmacy to respond to the pharmacy-based, selfadministered<br />

consumer interview schedule. Each pharmacy was asked to enrol up to 10<br />

customers to participate in the baseline <strong>and</strong> follow-up survey by completing the consumer<br />

questionnaire, in the pharmacy, at enrolment, <strong>and</strong> to consent to a follow-up telephone<br />

interview to complete the questionnaire at three months post enrolment. This sample size<br />

was considered to be achievable, based on the number of people with incontinence in the<br />

general population estimated to attend a community pharmacy, <strong>and</strong> the pilot Program trial<br />

period of three months was determined to provide pharmacies with sufficient time to recruit<br />

10 or more participating customers. It was expected that larger pharmacies would potentially<br />

recruit more than 10 participating consumers, <strong>and</strong> that smaller pharmacies would potentially<br />

recruit five or more over the three-month trial period. The project methodology proposed<br />

that the 500 recruited consumers would be asked to consent to a follow-up study, to be<br />

administered to a r<strong>and</strong>omly selected sub-sample of 300 respondents by Computer Aided<br />

Telephone Interview (CATI), by the market research firm Ipsos Australia.<br />

Recruitment of consumer participants in the evaluation of the pilot Program was promoted at<br />

the time of the <strong>Pharmacy</strong> Initial Questionnaire through an interviewer information guide;<br />

through provision of a comprehensive <strong>and</strong> substantial consumer information resource kit to<br />

each pharmacy (see Appendix 1.1.3), <strong>and</strong> through a financial incentive offering participation<br />

in a draw for travel vouchers for pharmacies that succeeded in recruiting 10 or more<br />

consumers, <strong>and</strong> for those who succeeded in recruiting five to nine consumer participants.<br />

Participating consumers were advised in a brief introductory letter, attached to the printed<br />

consumer questionnaire <strong>and</strong> signed by the Project Director, <strong>and</strong> again on the questionnaire,<br />

that their participation would be recognised by inclusion in a draw for a travel voucher.<br />

Despite these strategies, at the conclusion of the pilot Program operational period, at the<br />

end of July, only 24 consumer questionnaires had been returned. In an endeavour to<br />

improve this extremely low recruitment, the project team advised pharmacies, by electronic<br />

Final Report<br />

19<br />

NOVA Public Policy<br />

<strong>Pharmacy</strong> <strong>Continence</strong> <strong>Care</strong> Project

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!